Compounds > flomoxef
Page last updated: 2024-08-24

flomoxef and Neonatal Sepsis

flomoxef has been researched along with Neonatal Sepsis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Darlow, CA; Hope, W2
Da Costa, RMA; Darlow, CA; Das, S; Ellis, S; Farrington, N; Franceschi, F; Hope, W; Jimenez-Valverde, A; Johnson, A; Kolamunnage-Dona, R; McEntee, L; Neely, M; Piddock, LJV; Sharland, M; Unsworth, J1
Standing, JF1
Da Costa, RMA; Darlow, CA; Das, S; Ellis, S; Farrington, N; Franceschi, F; Hope, W; Jagota, B; Jimenez-Valverde, A; Johnson, A; Kolamunnage-Dona, R; McEntee, L; Neely, M; Piddock, L; Sharland, M; Unsworth, J1

Other Studies

5 other study(ies) available for flomoxef and Neonatal Sepsis

ArticleYear
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
    The Journal of antimicrobial chemotherapy, 2022, 02-23, Volume: 77, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis

2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
    The Journal of antimicrobial chemotherapy, 2022, 04-27, Volume: 77, Issue:5

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Fosfomycin; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis

2022
Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
    The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Klebsiella Infections; Neonatal Sepsis

2022
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response.
    The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Klebsiella Infections; Neonatal Sepsis

2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
    The Journal of antimicrobial chemotherapy, 2022, 11-28, Volume: 77, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Delivery of Health Care; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis

2022